Revolutionizing Drug Discovery & Development with Advanced 3D Models
In light of recent advancements, including the FDA Modernization Act 2.0 signed by President Biden in December 2022, the successful IND approval for a Phase 2 clinical trial using organ-on-chip data by Hesperos and Sanofi, and NIH's development of in vitro models for AMD using bio
16-18 May 2023